首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   945956篇
  免费   68843篇
  国内免费   1410篇
耳鼻咽喉   13098篇
儿科学   24617篇
妇产科学   23447篇
基础医学   135038篇
口腔科学   28673篇
临床医学   82146篇
内科学   186303篇
皮肤病学   19478篇
神经病学   73656篇
特种医学   37781篇
外国民族医学   79篇
外科学   154510篇
综合类   18207篇
现状与发展   1篇
一般理论   250篇
预防医学   62724篇
眼科学   21769篇
药学   73473篇
  3篇
中国医学   2179篇
肿瘤学   58777篇
  2018年   9388篇
  2017年   7351篇
  2016年   8123篇
  2015年   9325篇
  2014年   12617篇
  2013年   18243篇
  2012年   25300篇
  2011年   26271篇
  2010年   15535篇
  2009年   14968篇
  2008年   25640篇
  2007年   26778篇
  2006年   27427篇
  2005年   26325篇
  2004年   25405篇
  2003年   24340篇
  2002年   23748篇
  2001年   54963篇
  2000年   56771篇
  1999年   47134篇
  1998年   10863篇
  1997年   9571篇
  1996年   9669篇
  1995年   8994篇
  1994年   8334篇
  1993年   7650篇
  1992年   35587篇
  1991年   34004篇
  1990年   32819篇
  1989年   31942篇
  1988年   29066篇
  1987年   28331篇
  1986年   26343篇
  1985年   25211篇
  1984年   17911篇
  1983年   15192篇
  1982年   7852篇
  1981年   6817篇
  1979年   15858篇
  1978年   10651篇
  1977年   9102篇
  1976年   7914篇
  1975年   8664篇
  1974年   10497篇
  1973年   9897篇
  1972年   9392篇
  1971年   8887篇
  1970年   8458篇
  1969年   7958篇
  1968年   7218篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
992.
This study compared the clinical efficacy, safety, and tolerability of daily subcutaneous injections of teriparatide and salmon calcitonin in the treatment of postmenopausal women with established osteoporosis in Taiwan. This 6-month, multicenter, randomized, controlled study enrolled 63 women with established osteoporosis. They were randomized to receive either teriparatide 20 μg or calcitonin 100 IU daily in an open-label fashion. Lumber spine, femoral neck, total hip bone mineral density (BMD), and biochemical markers of bone turnover were measured, and adverse events and tolerability were recorded. The results at 6 months showed that patients using teriparatide had larger mean increases in spinal BMD than those who used calcitonin (4.5% vs. 0.1%), but the BMD changes in these two groups at the femoral neck and the total hip were not significant. There were also larger mean increases in bone markers in the teriparatide group than in the calcitonin group (bone specific alkaline phosphatase 142% vs. 37%; osteocalcin 154% vs. 23%). We conclude that teriparatide has more positive effects on bone formation than salmon calcitonin, as shown by the larger increments of lumbar spine BMD and bone formation markers, and caused only mild adverse events and no significant change in liver, kidney or hematological parameters. Compared with the published global results, teriparatide seems to be equally effective and safe to use in this Asian population.  相似文献   
993.
994.
995.
Molecular determinants of cetuximab efficacy.   总被引:17,自引:0,他引:17  
PURPOSE: To investigate whether mRNA expression levels of cyclin D1 (CCND1), cyclooxygenase 2 (Cox-2), epidermal growth factor receptor (EGFR), interleukin 8 (IL-8), and vascular endothelial growth factor (VEGF), all members of the EGFR signaling pathway, are associated with clinical outcome in patients with EGFR-expressing metastatic colorectal cancer (CRC) treated with cetuximab. PATIENTS AND METHODS: Thirty-nine patients with metastatic CRC, refractory to both irinotecan and oxaliplatin, were enrolled on IMCL-0144 and treated with single-agent cetuximab. The intratumoral mRNA levels of CCND1, Cox-2, EGFR, IL-8, and VEGF were assessed from paraffin-embedded tissue samples using laser-capture microdissection and quantitative real-time polymerase chain reaction. RESULTS: There were 21 women and 18 men with a median age of 64 years (range, 35 to 83 years). Higher gene expression levels of VEGF were associated with resistance to cetuximab (P = .038; Kruskal-Wallis test). The combination of low gene expression levels of Cox-2, EGFR, and IL-8 was significantly associated with overall survival (13.5 v 2.3 months; P = .028; log-rank test). Both findings were independent of skin toxicity that was itself significantly correlated to survival. Patients with a lower mRNA amount of EGFR had a longer overall survival compared with patients that had a higher mRNA amount (7.3 v 2.2 months; P = .09; log-rank test). Patients with lower expression of Cox-2 had a significantly higher rate of grade 2 to 3 skin reactions under cetuximab treatment. CONCLUSION: This pilot study suggests that gene expression levels of Cox-2, EGFR, IL-8, and VEGF in patients with metastatic CRC may be useful markers of clinical outcome in single-agent cetuximab treatment.  相似文献   
996.
997.
In-flight encounters with hazardous weather represent one of the most significant safety issues in civil aviation operations. Aircrew judgment is often cited as the probable cause of incidents and accidents involving weather, although lack of information is also a factor. The present study examines how information, presented at different times and in different forms, affects the awareness and decision-making behavior of aircrews in a flight simulation study of a recent microburst/windshear incident. In order to examine the influence of enhanced information transfer on aircrew behavior, intracrew communications and approach-to-land decisions were evaluated with conventional ATC communications and with automated cockpit alerting and display of weather information. Results of the study revealed that aircrews provided only with conventional ATC transmissions of weather information had difficulty discriminating conditions conducive to microburst events from less hazardous windshear events. Improved situation awareness for microburst events was found when ground-based convective weather information was provided in real time to aircrews. Avoidance decision-making was found to be less efficient with conventional ATC alert transmissions when compared to the performance of crews provided with a visual display of microburst events. The importance of information transfer on aircrew situation awareness and decision-making in hazardous weather avoidance is discussed.  相似文献   
998.
999.
1000.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号